US Merger & Acquisition SEC Filings — July 29, 2026

29-07-2026

Westin Acquisition Corp (Nasdaq: WSTNU) announced a definitive business combination agreement with First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) to create a publicly traded healthcare and wellness company. The transaction values First Choice at a pro forma enterprise value of approximately $650 million and is expected to close in Q4 2026. The combined company will rebrand as Wellgevity 360, focusing on longevity, preventative care, and personalized medicine, and will trade on Nasdaq.

• · The transaction implies a pre-money equity value of approximately $650 million for First Choice Healthcare.
• · The combined company is expected to trade on Nasdaq.
• · Transaction expected to close in Q4 2026, subject to regulatory and shareholder approvals.
• · Westin will domesticate from the Cayman Islands to Nevada prior to closing.
• · The global wellness economy is forecast to reach $9.8 trillion by 2029 at a 7.6% annual growth rate.
• · Millennials and Gen Z are driving a 'prejuvenation' trend in the wellness market.
• · The business model emphasizes cash-pay services to reduce insurance dependency and membership programs for recurring revenue.

29-07-2026

Iron Horse Acquisition II Corp. (IRHO) and Electra Vehicles, Inc. (Electra) announced that Electra AI contributed to a Volta Foundation insights paper on battery storage in data center applications. The paper argues that AI buildout is now gated by power delivery speed, with battery storage (BESS) deployable in 12-18 months versus multi-year waits for gas turbines and transformers. This is a non-financial, forward-looking update with no quantitative financial data or period-over-period comparisons.

• · Battery storage (BESS) deployment timeline: 12-18 months vs. multi-year waits for gas turbines and transformers.
• · Grid connections now take more than four years in most U.S. markets.
• · The paper maps where batteries win, compete, and fall short in data center applications.
• · Electra AI's platform focuses on real-time monitoring, optimization, and control of battery systems to maximize ROI and safety.

29-07-2026

Rising Dragon Acquisition Corp. (RDACU) issued a $55,637.41 promissory note to SZG Limited on June 15, 2026, to extend the time available to consummate its initial business combination. The note is non-interest bearing and convertible into private units at $10.00 per unit upon closing of the business combination. If the merger agreement is terminated under certain conditions or the business combination does not close, the note will be terminated with no amounts due.

• · The note is dated June 15, 2026, and the initial public offering prospectus is dated October 10, 2024.
• · The merger agreement with SZG Limited and other parties was signed on January 27, 2025.
• · Proceeds from the note must be deposited into the trust account to extend the time for the business combination.
• · No interest accrues on the note.
• · The note is governed by New York law and the parties waive jury trial rights.
• · The payee (SZG Limited) waives any claim against the trust account, limiting recourse to assets outside the trust.

29-07-2026

Inflection Point Acquisition Corp. III disclosed that as of July 27, 2026, it had received redemption requests for 24,673,661 of its Class A ordinary shares in connection with its pending business combination with Air Water Ventures Holdings Limited. The company also entered into an agreement with a service provider to pay a cash fee equal to 125,000 multiplied by the redemption price, contingent on the service provider holding 125,000 non-redeemed shares at closing; however, as of the filing date, the service provider had not yet purchased any shares. The high redemption volume indicates significant shareholder exit, while the service provider incentive aims to reduce redemptions.

• · The service provider agreement requires the provider to show evidence within five business days of closing that it held 125,000 non-redeemed Class A ordinary shares.
• · Any subsequent share purchases by the service provider would be made at prices not exceeding the redemption price.
• · The registration statement for the business combination was declared effective by the SEC on July 8, 2026.
• · The record date for shareholder voting on the business combination was June 24, 2026, with proxy mailing beginning July 9, 2026.

29-07-2026

Processa Pharmaceuticals, Inc. (PCSA) announced the acquisition of Vidya Therapeutics, Inc., adding the next-generation BTK inhibitor VT-7208 to its pipeline. Concurrently, the company secured an oversubscribed private placement of approximately $200 million from a syndicate of leading healthcare investors. The combined cash is expected to fund operations into the second half of 2029, with Phase 2 proof-of-concept data anticipated in food allergy (2H 2027), CSU (1H 2028), and RMS (2H 2028). However, existing Processa stockholders will be diluted to only about 0.9% ownership on a fully-diluted basis, while Vidya equity holders and new investors will own approximately 46.0% and 52.6%, respectively.

• · VT-7208 is a CNS-penetrant, once-daily, oral covalent BTKi designed to minimize off-target kinase activity and reduce hepatotoxicity risk relative to earlier BTKis.
• · In Phase 1, VT-7208 demonstrated robust target engagement, durable pharmacodynamic activity, and predictable dose-dependent pharmacokinetics in both CSF and periphery, with no serious adverse events.
• · Processa expects to initiate Phase 2 studies in food allergy and CSU in 2H 2026, and in RMS in 1H 2027.
• · The acquisition and private placement closings are not subject to Processa stockholder approval; stockholder approval is required only for conversion of the Series A preferred stock.
• · Processa intends to continue development of legacy assets PCS499 and PCS12852 alongside the BTK inhibitor program.

29-07-2026

Ocean Capital Acquisition Corp announced that holders of its IPO units may elect to separately trade the underlying ordinary shares, rights, and warrants starting August 3, 2026. The units will continue to trade under the symbol OCACU on the NYSE, while the separated components will trade under OCAC, OCACR, and OCACW. This is a procedural step enabling separate trading of the SPAC's securities components.

• · Separate trading of ordinary shares, rights, and warrants begins on August 3, 2026.
• · Holders must contact Odyssey Transfer and Trust Company LLC via their brokers to separate units.
• · The company is an emerging growth company as defined under SEC rules.

29-07-2026

Catalyst Acquisition Corp., a blank check company, announced the pricing of its $200 million initial public offering of 20,000,000 units at $10.00 per unit, with units trading on Nasdaq under the symbol "CATLU" starting July 28, 2026. The offering is expected to close on July 29, 2026, and the company intends to focus on acquisition opportunities in traditional and digital media sectors, including video games and mobile gaming. The company has granted the underwriter a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.

• · The units will trade on Nasdaq under the symbol "CATLU" starting July 28, 2026.
• · The Class A ordinary shares and rights are expected to begin separate trading no later than the 52nd day following the IPO date, under symbols "CATL" and "CATLR" respectively.
• · Santander is acting as sole book-running manager for the offering.
• · The company is a blank check company formed to pursue a business combination, with a focus on traditional and digital media sectors including video game companies, mobile gaming, publishers, studios, and media platforms.
• · The registration statement for the securities became effective on July 27, 2026.

29-07-2026

Medalist Diversified REIT, Inc. completed the acquisition of a 1.64-acre automotive service property in Overland Park, Kansas for $5.8 million in cash on July 29, 2026. The property was acquired through a Delaware statutory trust (DST), and the company plans to offer beneficial interests in the DST to accredited investors in a private placement, with proceeds used to redeem the company's interests. The acquisition was funded from cash on hand, and no debt or equity issuance was involved.

• · The acquisition was previously disclosed in a Form 8-K filed on June 9, 2026.
• · The seller was unaffiliated, and the transaction was at arm's length.
• · The DST was formed specifically to acquire and hold title to the property.
• · Financial statements and pro forma financial information will be filed within 71 days of this report.

29-07-2026

The filing is an 8-K submitted by Constellation Acquisition Corp I on July 29, 2026, under Item 2.03, reporting the creation of a direct financial obligation. The filing does not disclose any merger or acquisition details, deal structure, strategic rationale, valuation, or shareholder impact. No specific financial metrics, transaction values, or named parties are provided. The filing is purely informational regarding a debt obligation, with no positive or negative performance metrics to balance.

29-07-2026

B&R Technology Sponsor LLC (Cayman) and related entities filed a Schedule 13D disclosing beneficial ownership of 13,145,833 ordinary shares (28.8% of the outstanding shares) of B&R Technology Merger Corp. as of July 22, 2026. The filing details the acquisition of 687,500 Placement Units for $6,875,000 and 12,458,333 Founder Shares for $25,000, with up to 1,625,000 shares subject to forfeiture depending on the underwriter's over-allotment option. The reporting persons include the Sponsor, Authentic Holdings, Authentic Founders, Steven Fletcher, and Alex Vieux, who disclaim beneficial ownership except for their pecuniary interest.

• · The Sponsor purchased 11,500,000 Founder Shares on December 29, 2025 for $25,000, and received an additional 958,333 Founder Shares on July 1, 2026 in a share recapitalization for no consideration.
• · The Placement Units were purchased on July 22, 2026 simultaneously with the IPO at $10.00 per unit; each unit consists of one Class A ordinary share and one-third of a warrant exercisable at $11.50 per share.
• · Up to 1,625,000 Class B ordinary shares are subject to forfeiture depending on the extent of the underwriter's over-allotment option exercise.
• · The Sponsor's principal business is to act as the Issuer's sponsor; the reporting persons acquired the shares for investment purposes.
• · None of the reporting persons has been convicted in a criminal proceeding or been subject to securities-related civil proceedings in the last five years.

29-07-2026

On July 29, 2026, D. Boral ARC Acquisition I Corp. (BCAR) held an extraordinary general meeting where shareholders approved the business combination with Exascale Labs Inc., including the domestication merger to re-domicile from the British Virgin Islands to Delaware and rename the combined entity to Exascale Labs Holdings Inc. All seven proposals were approved by wide margins (over 95% of votes cast in favor), and five directors were elected. However, a massive 95.95% of outstanding public shares (26,865,211 Class A ordinary shares) were elected for redemption, indicating overwhelming shareholder dissent or desire to exit, which will significantly reduce the cash available for the combined company.

• · The Business Combination Proposal received 24,503,325 votes FOR, 1,120,108 AGAINST, and 35,000 ABSTAIN.
• · The Domestication Merger Proposal received 24,502,235 FOR, 1,121,108 AGAINST, and 35,000 ABSTAIN.
• · The Organizational Documents Proposal received 24,502,235 FOR, 1,121,108 AGAINST, and 35,000 ABSTAIN.
• · Advisory Organizational Documents Proposal 4B (Change in Voting Rights) had the highest opposition with 1,781,108 AGAINST votes.
• · The Equity Incentive Plan Proposal received 24,520,580 FOR, 1,109,708 AGAINST, and 28,055 ABSTAIN.
• · The Nasdaq Proposal received 24,523,635 FOR, 1,109,708 AGAINST, and 25,000 ABSTAIN.
• · Proposal No. 8 (Adjournment) was not presented due to sufficient votes for all other proposals.
• · The press release announcing the approval was issued on July 29, 2026 and furnished as Exhibit 99.1.